Asuragen

📍 Austin, United States🗓 Founded 2006👥 140 employees💰 Last funded 2006
Biotechnology🌐 asuragen.com
Website LinkedIn
Asuragen a Bio-Techne brand is a molecular diagnostic product company changing the way patients are treated in genetics and oncology. Asuragen’s diagnostic systems, composed of proprietary chemistry and software, deliver powerful answers using broadly installed instrument platforms. They are simple to adopt and expand the ability to serve patients. Asuragen is a product foundry rapidly and efficiently addressing current and emerging clinical needs, including cancer diagnosis and monitoring, reproductive health and aging, serving laboratories across a patient’s lifespan with its best in class diagnostic tests. Bio-Techne a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2006
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in Asuragen?
Asuragen has 1 investor on record on gritt.io, including 1 early-stage backers.
When did Asuragen last raise funding?
The most recent investment in Asuragen recorded on gritt.io was in 2006.
When was Asuragen founded?
Asuragen was founded in 2006.
What industry is Asuragen in?
Asuragen operates in Biotechnology. Find similar Biotechnology investors on gritt.io.
Where is Asuragen based?
Asuragen is headquartered in Austin, United States.